Solvonis Therapeutics plc (LON:SVNS)

London flag London · Delayed Price · Currency is GBP · Price in GBX
0.1650
+0.0200 (13.79%)
At close: May 9, 2025, 4:30 PM BST
0.00%
Market Cap 3.79M
Revenue (ttm) n/a
Net Income (ttm) -1.59M
Shares Out 2.30B
EPS (ttm) -0.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 26,016,086
Average Volume 4,533,110
Open 0.1500
Previous Close 0.1450
Day's Range 0.1490 - 0.1695
52-Week Range 0.1000 - 1.4070
Beta 1.62
RSI 59.54
Earnings Date Apr 25, 2025

About Solvonis Therapeutics

Solvonis Therapeutics plc, together with its subsidiaries, researches and develops polymer modification technologies and techniques in the United Kingdom, Slovenia, and Europe. The company offers GRAFTABOND, a line of graft/block copolymers for combining various polymers with fiberglass, carbon fiber, mineral, natural fillers, and mixed polymer waste; GRAFTALEN, a line of reactive solid super-concentrates for polyolefin rheology modification, e-modulus enhancers, PET/PBT chain extenders, and AOX masterbatch; and GRAFTAPOR, a line of porous poly... [Read more]

Industry Plastics Materials, Synthetic Resins, and Nonvulcanizable Elastomers
Founded 2017
Employees 3
Stock Exchange London Stock Exchange
Ticker Symbol SVNS
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.